Latest News
FDA Warning Letters
The MHRA has reviewed its current approach to contacting UK Licence Holders who may be implicated by USFDA Warning Letters
Emerging issues – Communique from the GPhC
As part of maintaining professional vigilance and regulatory compliance across pharmacy services, PCL would like to draw attention to several critical issues recently highlighted by the General Pharmaceutical Council (GPhC).
New MHRA/NICE Collaboration
The UK is entering a new phase of innovation in how it regulates, assesses, and adopts new medicines—and it’s a development the global pharmaceutical and biopharmaceutical industry cannot afford to overlook.